Fund profile
Tickers
PBE
Fund manager
Total assets
$310.95 mm
Liabilities
$54.77 mm
Net assets
$256.19 mm
Number of holdings
33.00
PBE stock data
33 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
Invesco Private Prime Fund | 39.36 mm | 39.36 mm shares | 15.36 | Short-term investment vehicle | Long | USA |
ILMN Illumina Inc | 16.46 mm | 115.13 k shares | 6.43 | Common equity | Long | USA |
Invesco Private Government Fund | 15.08 mm | 15.08 mm shares | 5.89 | Short-term investment vehicle | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 14.35 mm | 102.69 k shares | 5.60 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 13.65 mm | 31.49 k shares | 5.33 | Common equity | Long | USA |
AMGN AMGEN Inc. | 13.31 mm | 42.35 k shares | 5.19 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 13.21 mm | 14.02 k shares | 5.16 | Common equity | Long | USA |
BIIB Biogen Inc | 12.04 mm | 48.83 k shares | 4.70 | Common equity | Long | USA |
IMGN Immunogen, Inc. | 12.03 mm | 410.26 k shares | 4.70 | Common equity | Long | USA |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 11.31 mm | 128.38 k shares | 4.41 | Common equity | Long | USA |
UTHR United Therapeutics Corp | 10.54 mm | 49.07 k shares | 4.11 | Common equity | Long | USA |
CLDX Celldex Therapeutics Inc. | 7.93 mm | 225.09 k shares | 3.09 | Common equity | Long | USA |
COLL Collegium Pharmaceutical Inc | 7.89 mm | 239.52 k shares | 3.08 | Common equity | Long | USA |
TGTX TG Therapeutics Inc | 7.76 mm | 478.11 k shares | 3.03 | Common equity | Long | USA |
RGEN Repligen Corp. | 7.46 mm | 39.38 k shares | 2.91 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 7.40 mm | 93.04 k shares | 2.89 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 7.26 mm | 339.39 k shares | 2.83 | Common equity | Long | USA |
PTCT PTC Therapeutics Inc | 7.21 mm | 276.47 k shares | 2.82 | Common equity | Long | USA |
VCEL Vericel Corp | 7.18 mm | 167.15 k shares | 2.80 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies Inc | 7.05 mm | 104.67 k shares | 2.75 | Common equity | Long | USA |
ACAD Acadia Pharmaceuticals Inc | 6.93 mm | 267.42 k shares | 2.70 | Common equity | Long | USA |
ALKS Alkermes plc | 6.86 mm | 253.49 k shares | 2.68 | Common equity | Long | Ireland |
ARWR Arrowhead Pharmaceuticals Inc. | 6.81 mm | 212.09 k shares | 2.66 | Common equity | Long | USA |
QGEN Qiagen NV | 6.70 mm | 153.50 k shares | 2.62 | Common equity | Long | Netherlands |
CPRX Catalyst Pharmaceuticals Inc | 6.44 mm | 447.07 k shares | 2.51 | Common equity | Long | USA |
EXEL Exelixis Inc | 6.37 mm | 292.85 k shares | 2.49 | Common equity | Long | USA |
VCYT Veracyte Inc | 5.89 mm | 235.38 k shares | 2.30 | Common equity | Long | USA |
DVAX Dynavax Technologies Corp. | 5.79 mm | 448.05 k shares | 2.26 | Common equity | Long | USA |
FLGT Fulgent Genetics Inc | 5.46 mm | 221.92 k shares | 2.13 | Common equity | Long | USA |
MNKD Mannkind Corp | 5.44 mm | 1.63 mm shares | 2.13 | Common equity | Long | USA |
HALO Halozyme Therapeutics Inc. | 5.19 mm | 153.20 k shares | 2.02 | Common equity | Long | USA |
OPK Opko Health Inc | 4.22 mm | 4.14 mm shares | 1.65 | Common equity | Long | USA |
Invesco Government & Agency Portfolio, Institutional Class | 317.40 k | 317.40 k shares | 0.12 | Short-term investment vehicle | Long | USA |